California’s Applied Molecular Transport has become the latest biotech to go for an IPO during the pandemic, aiming to raise $100 million to take an oral ulcerative colitis drug into phase 2 ...

PanARMENIAN.Net - Arusyak Manavazyan, Head of the Civil Contract party’s staff, announced that 380 people have submitted applications to run as MP candidates under the party’s banner for the 2026 ...

Understanding the differences between AMT, CVT and DCT can help you choose the appropriate transmission for your needs. Choosing the right car transmission can be confusing. With so many options ...

The manual gearbox is dying, but in certain regions, it has a new lease of life as it is being replaced by the AMT — Automated Manual Transmission. While AMTs may not be common in the United States, ...

On Tuesday, the IRS released Notice 2025-49, which provides interim guidance regarding the application of the CAMT. The proposed regulations address the application of the CAMT and technical ...

The Yogurt Shop Murders were the subject of a four-part documentary released on HBO this year. On Friday, police said DNA evidence collected at the crime scene linked Robert Eugene Brashers to the ...

FRIDAY, Sept. 26, 2025 (HealthDay News) — A new gene therapy has shown promise in slowing the progression of Huntington’s disease, according to early trial results released Wednesday. In a Phase 1/2 ...

For many investors, the phrase "alternative minimum tax" tends to raise eyebrows or trigger confusion, if not concern. However, within the municipal bond market, AMT-designated bonds are quietly ...

Interim guidance issued Tuesday by the IRS on the Sec. 55 corporate alternative minimum tax (AMT) contains several changes for which the AICPA advocated. One such change in Notice 2025-28 is the ...

The IRS on Monday issued interim guidance regarding the application of the Sec. 55 corporate alternative minimum tax (AMT). The guidance in Notice 2025-27 provides an optional simplified method for ...

uniQure recently divested from its Lexington facility to Genezen and freed $25 million while significantly reducing its operating costs. At the same time, AMT-130 has received the FDA’s Breakthrough ...